Cynomolgus Monkey Serum

<strong>Cynomolgus Monkey Serum</strong>_x000D_ <strong>Catalog number:</strong> B2014566_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Serum_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> Cynomolgus Monkey Serum_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Zhou A, Yu J, Wu Y, Xue H, Zhong D, Diao X. A validated LC-MS/MS method for the quantification of bevacizumab in rat, cynomolgus_monkey, and human serum J Pharm Biomed Anal. 2023 Oct 25;235:115590._x000D_ 2: Liu T, Tong Y, Gao J, Fang W, Wu J, Peng X, Fan X, Chen X, Sun J, Cao S, Li Z, Gong L, Qin Q, Ju D. Development of a bridging ELISA for detection of antibodies against ZV0203 in cynomolgus monkey serum J Pharmacol Toxicol Methods. 2023 Jan-Feb;119:107210._x000D_ 3: Cao H, Zhang G, Ciociola K, Amaravadi L, Qiu Y, Wu J. An LC-MS/MS approach to assess total and free protein target in the serum of cynomolgus _monkey Bioanalysis. 2019 Mar;11(5):393-406._x000D_ 4: Tian C, Qiu M, Lv H, Yue F, Zhou F. Preliminary serum and fecal metabolomics study of spontaneously diabetic cynomolgus_monkeys based on LC-MS/MS J Med Primatol. 2022 Dec;51(6):355-366._x000D_ 5: Yoshida T, Yokota K, Cho F, Honjo S. Radioreceptor assay for cynomolgus_monkey serum luteinizing hormone Endocrinol Jpn. 1984 Oct;31(5):665-73._x000D_ 6: Xu H, Kitano E, Sato Y, Kobayashi C, Firdawes S, Kitamura H, Fukuzawa M, Miyagawa S. Studies of monkey complement: measurement of cynomolgus_monkey CH50, ACH50, C4, C2 and C3 Xenotransplantation. 2008 Feb;15(1):14-9._x000D_ 7: Wang S, Wang F, Wang L, Liu Z, Liu M, Li S, Wang Y, Sun X, Jiang J. Detection of antibody-conjugate payload in cynomolgus_monkey serum by a high throughput capture LC-MS/MS bioanalysis method J Pharm Biomed Anal. 2023 Apr 1;227:115069._x000D_ 8: Liu T, Sun Y, Deng X, Shi L, Chen W, Fang W, Wu J, Fan X, Chen X, Sun J, Qin G, Gong L, Qin Q. Development, Validation and Application of a Bridging ELISA for Detection of Antibodies against GQ1001 in Cynomolgus Monkey Serum Molecules. 2023 Feb 10;28(4):1684._x000D_ 9: Gui LL, Li L, Dong LH, Xiang SS, Zhai JP, Ge ZQ, Song HF. Method development and validation of LC-MS/MS-based assay for the simultaneous quantitation of trastuzumab and pertuzumab in cynomolgus monkey serum and its application in pharmacokinetic study Biomed Chromatogr. 2020 Dec;34(12):e4903._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34953862">10: Frances N, Bacac M, Bray-French K, Christen F, Hinton H, Husar E, Quackenbush E, Schäfer M, Schick E, Vyver AV, Richter WF. Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab J Pharm Sci. 2022 Apr;111(4):1208-1218. </a>_x000D_ _x000D_ <strong>Products Related to Cynomolgus Monkey Serum can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>